EP Patent
EP2887925B1 — Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
Assigned to Roehm GmbH Darmstadt · Expires 2017-02-22 · 9y expired
What this patent protects
Patent listed against Prilosec.
Drugs covered by this patent
- Prilosec (omeprazole) · AstraZeneca (originally Astra AB)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.